Columbia President Nemat Shafik Resigns After Israel-Hamas War Turmoil
Nemat Shafik is the third Ivy League president to resign in the wake of turbulent congressional appearances and strife connected to the Israel-Hamas war. Columbia University’s president, Nemat Shafik, resigned on Wednesday after months of far-reaching fury over her handling of pro-Palestinian demonstrations and questions over her management of a bitterly divided campus.She was the third leader of an Ivy League university to resign in about eight months following maligned appearances before Congress about antisemitism on their campuses.Dr. Shafik, an economist who spent much of her career in London, said in a letter to the Columbia community that while she felt the campus had made progress in some important areas, it had also been a period of turmoil “where it has been difficult to overcome divergent views across our community.”“This period has taken a considerable toll on my family, as it has for others in our community,” wrote Dr. Shafik, who goes by the name Minouche. “Over the summer, I have been able to reflect and have decided that my moving on at this point would best enable Columbia to traverse the challenges ahead.”She added that her resignation was effective immediately, and that she would be taking a job with Britain’s foreign secretary to lead a review of the government’s approach to international development.The university’s board of trustees named Dr. Katrina A. Armstrong, a medical doctor who has been the chief executive of Columbia’s medical center and dean of its medical school since 2022, as the interim president. The board did not immediately announce a timeline for appointing a permanent leader.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More